Descompensated Hepatic Cirrosis clinical trials

Explore recruiting descompensated hepatic cirrosis clinical trials.

Also recruiting in Europe

Descompensated Hepatic Cirrosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

LIVER AKI: A randomized, open-label trial to evaluate the efficacy of intravenous human albumin administration versus saline solution (NaCl 0.9%) in patients with decompensated cirrhosis and AKI 1B or grater.

Spain

Therapeutic use (Phase IV) EU CTIS Study details

Descompensated Hepatic Cirrosis trials by city

Descompensated Hepatic Cirrosis in Toronto Descompensated Hepatic Cirrosis in Vancouver Descompensated Hepatic Cirrosis in Montreal Descompensated Hepatic Cirrosis in Calgary Descompensated Hepatic Cirrosis in Edmonton Descompensated Hepatic Cirrosis in Ottawa Descompensated Hepatic Cirrosis in Winnipeg Descompensated Hepatic Cirrosis in Quebec City Descompensated Hepatic Cirrosis in Hamilton Descompensated Hepatic Cirrosis in Kitchener Descompensated Hepatic Cirrosis in London Descompensated Hepatic Cirrosis in Halifax Descompensated Hepatic Cirrosis in New York Descompensated Hepatic Cirrosis in Los Angeles Descompensated Hepatic Cirrosis in Chicago Descompensated Hepatic Cirrosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease